Propanc Biopharma announced plans to build a crypto treasury of up to $100 million, with backing from Hexstone Capital, to support the development of its experimental cancer treatment and revive investor interest.

The company says the crypto treasury will provide enhanced liquidity, transparency, and security while helping fund research and potential clinical trials. This move highlights a growing intersection between biopharma financing and blockchain-based asset management.

If realized, the $100M crypto fund could accelerate Propanc’s development timeline and set a precedent for alternative funding strategies in the healthcare sector.